PMC

(A) H^N–H^N region of the homonuclear NOESY spectrum (t_mix = 200 ms, pH 6.0) of LigB_1703–1717 in PBS in H₂O. The d_NN cross-peaks are labeled with residue numbers, and arrows indicate sequential connectivities. The NOEs between sequential residues in residues A₁₇₁₁ through F₁₇₁₅ indicate nascent helical character. (B) Plot of the difference in H^α chemical shifts, or Δδ_Hα, between observed and random coil values for LigB_1703–1717. (C) Indicated the first cysteine conjugated on LigB_1703–1717. A stretch of Δδ_Hα values below −0.1 indicates nascent α-helical structure, and a stretch of values above 0.1 indicates preference for β-strand conformation.

The binding of LigB_1706–1716 to MDCK cells reduces leptospiral adhesion. (A) Various concentrations (0, 2, 4, 6, 8, or 10 μM) of biotin-LigB_1706–1716, or biotin (negative control) were added to MDCK cells (10⁵). (B,C) LigB_1706–1716 inhibits the binding of Leptospira to MDCK cells. (B) MDCK cells (10⁵) were incubated with various concentrations (0, 2, 4, 6, or 8, 10 μM) of biotin-LigB_1706–1716, or biotin (negative control) prior to the addition of Leptospira (10⁷). (A) The binding or (B) the reduced attachment was measured by ELISA. (C) The adhesion of Leptospira (10⁸) or the binding of 10 μM of biotin or biotin-LigB_1706–1716 to MDCK cells (10⁶) was detected by CLSM.

Identification of Fn-binding residues on LigBCtv. (A) A schematic diagram showing the truncated LigBCtv used in this study. (B) The Fn-binding activity of LigBCtv1, LigBCtv2, LigBCtv3, and LigBCtv4 regions. (C) The Fn-binding activity of the 30mers peptides from LigBCtv. (D) The synthetic peptide sequences (11mers) with overlapping regions used to identify the essential amino acids (indicated in bold) required for Fn binding. (E) The synthetic peptides indicated in (D) used in the Fn-binding assays. Various concentrations (40, 20, 10, 5, 2.5, 1.25, and 0.625 μM) of each tested biotinylated-protein or -peptide, -BBK32_56–205 (positive control; B, C, and E), -LigBCon (negative control; B) or -scrambled peptide (negative control; C and E) were used in this study. Bound proteins or peptides were measured by ELISA.

Mapping and characterization of LigB_1706–1716 binding sites on Fn. (A) A chart presenting Fn and truncated Fn used in this study. (B,C) Various concentration (0.625, 1.25, 2.5, 5, 10, 20, 40 μM) of biotin-LigB_1706–1716 or biotin (negative control and data not shown) were added to 1 μg of (B) Fn, NTD, GBD, CBD, 40 kDa, or BSA (negative control) (C) 40 kDa, MBP-12–13F₃, MBP-14F₃, MBP-15F₃, MBP (negative control), or BSA (negative control) coated microtiter plate wells. Bound proteins were measured by ELISA. (D) 1 μM of 15F₃ in PBS in the presence of 0, 0.625, 1.25, 2.5, 5, 10, 20 and 40 μM of LigB_1706–1716 was excited at 295 nm to measure Trp fluorescence. Inner plot: K_D of 15F₃-LigB_1706–1716 determined by monitoring quenching fluorescence intensities at 350 nm. (E) Stop flow experiment of 15F₃ binding to LigB_1706–1716. The signal represents the total fluorescence emission above 320 nm by excited at 295 nm. Inner plot: The kinetic plot of k_obs versus concentration of 1 μM 15F₃ under different LigB_1706–1716 concentrations (25, 50, 100, 200, 400 μM).